636603-08-2

Upstream product

• 636603-07-1 8-(tert-butyl-dimethyl-silanyloxymethyl)-5-[1-(tert-butyl-diphenyl-silanyloxymethyl)-vinyl]-12-methyl-15-(tetrahydro-pyran-2-yloxy)-pentadeca-7,11-dien-2-ol 
• 636603-05-9 6-(tert-butyl-diphenyl-silanyloxymethyl)-2-[4-methyl-7-(tetrahydro-pyran-2-yloxy)-hept-3-enyl]-5-(3-oxo-butyl)-hepta-2,6-dienoic acid ethyl ester 
• 905458-50-6 (Z)-(S)-5-[1-(tert-Butyl-diphenyl-silanyloxymethyl)-vinyl]-2-[(E)-4-methyl-7-(tetrahydro-pyran-2-yloxy)-hept-3-enyl]-non-2-ene-1,8-diol 
• 636603-06-0 4-(tert-butyl-diphenyl-silanyloxymethyl)-3-(3-oxo-butyl)-pent-4-enal 
• 340155-84-2 5-tetrahydropyranyloxy-2-cyclopropyl-2-pentanol 
• 5989-54-8 (-)-(S)-limonene 
• 10067-33-1 (S)-(-)-p-mentha-1,8⁽¹⁰⁾-dien-9-ol 
• 636603-04-8 8-(tert-butyl-dimethyl-silanyloxymethyl)-12-(tert-butyl-diphenyl-silanyloxymethyl)-4-methyl-11-(3-oxo-butyl)-trideca-4,8,12-trienal 

Downstream Products

• 148149-83-1 pseudoplexaurol 

Relevant academic research and scientific papers

Asymmetric Total Synthesis of Pseudoplexaurol and 14-Deoxycrassin, two Antitumor Marine Cembrane Diterpenoids

The first asymmetric total synthesis of two naturally occurring antitumor pseudoplexaurol and 14-deoxycrassin were achieved via two convergent synthetic sequences featured a chiral pool protocol to implement C-1 stereogenic center and Ti(0)-mediated cyclization leading to cembrane ring.